Literature DB >> 11093527

Myositis ossificans of the chest wall simulating malignant neoplasm.

J T Kim1, Y H Yoon, W K Baek, J Y Han, Y C Chu, H J Kim.   

Abstract

Myositis ossificans originating from the chest wall is extremely rare. We report a case of myositis ossificans occurring in a young woman with progressive painful swelling in the chest wall. Preoperative examination suggested a malignant neoplasm originating from soft tissue. Although rare, myositis ossificans is one of the potential causes of painful swelling in the chest wall, and can be mistaken for a malignant neoplasm.

Entities:  

Mesh:

Year:  2000        PMID: 11093527     DOI: 10.1016/s0003-4975(00)01688-x

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  5 in total

1.  Myositis ossificans of the abdominal rectus muscle: report of a case.

Authors:  Eun-Jung Jung; Young-Joon Lee; Soon-Tae Park; Woo-Song Ha; Sang-Kyung Choi; Soon-Chan Hong; Chi-Young Jeong; Young-Tae Joo; Jae-Bum Na; Gyung-Hyuck Ko
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

Review 2.  Imaging and diagnostic strategy of soft tissue tumors in children.

Authors:  Hervé Brisse; Daniel Orbach; Jerzy Klijanienko; Paul Fréneaux; Sylvia Neuenschwander
Journal:  Eur Radiol       Date:  2006-01-13       Impact factor: 5.315

3.  Intercostal myositis ossificans misdiagnosed as osteosarcoma in a 10-year-old child.

Authors:  Mériam Koob; Jean Durckel; Jean-Claude Dosch; Natacha Entz-Werle; Jean-Louis Dietemann
Journal:  Pediatr Radiol       Date:  2010-07-08

4.  Myositis ossificans in the right inferior thoracic wall as an unusual cause of lower thoracic-upper abdominal pain: report of a case.

Authors:  Tarkan Ergun; Hatice Lakadamyali; Huseyin Lakadamyali; Ertan Gokay
Journal:  Surg Today       Date:  2008-09-27       Impact factor: 2.549

5.  Stone man: a case report.

Authors:  Hamed Mortazavi; Majid Eshghpour; Mahdi Niknami; Morteza Saeedi
Journal:  Iran J Radiol       Date:  2012-12-27       Impact factor: 0.212

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.